Tempus AI (TEM) Q1 2026 Earnings
How Did TEM Stock React to Q1 2026 Earnings?
S&P 500 over the same 30 days: +0.73%.
Did TEM Beat Earnings? Q1 2026 Results
Yes. Tempus AI reported Q1 2026 earnings of $-0.13 a share on May 5, 2026, beating the $-0.20 consensus estimate by 35.4%. Revenue was $348.1M against a $345.4M estimate.
Tempus AI delivered a notably strong first quarter for fiscal 2026, with revenue of $348.12 million growing 36.1% year-over-year and edging past the $345.44 million consensus estimate, while a non-GAAP loss of $0.13 per share came in well ahead of the $0.20 consensus by 35.36%, reflecting meaningful operational progress. The primary engine behind the beat was broad-based momentum across both segments, with Diagnostics generating $261.10 million on 34.7% growth and Data and Applications contributing $87.02 million on 40.5% growth, the latter driven largely by surging biopharma demand for data licensing and AI modeling services. Gross margin expanded to 63.8% from 60.7% a year ago, and Adjusted EBITDA narrowed to a loss of just $2.83 million versus negative $16.17 million in the prior-year period. <a href="https://247wallst.com/investing/2026/05/04/can-nancy-pelosis-favorite-ai-stock-hope-to-regain-its-momentum/">TEM's recent momentum</a> continued into the outlook, as management raised full-year 2026 revenue guidance to $1.59 to $1.60 billion while reaffirming approximately $65 million in full-year Adjusted EBITDA.
- Oncology diagnostic volume growth of 28% year-over-year
- Hereditary volume growth of 54% (7% adjusted for Ambry pre-acquisition volumes)
- MRD volume of approximately 6,500 tests, up ~500% year-over-year
- Insights (data licensing and modeling) revenue growth of 44.1% year-over-year
- Gross margin expansion to 63.8% from 60.7% year-over-year
“Our strong financial and operational performance this quarter underscores the accelerating demand for our AI-driven diagnostic platform and the immense value of our multimodal data and corresponding AI models.”
Tempus AI CEO, on the earnings call
What Was Tempus AI's Outlook in Q1 2026?
Tempus raised full-year 2026 revenue guidance to $1.59 billion–$1.60 billion, representing approximately 25% annual growth, up from prior guidance. The company continues to expect full-year 2026 Adjusted EBITDA of approximately $65 million.
TEM YoY Financials
| Metric | Q1 2026 | Q1 2025 | Year over year |
|---|---|---|---|
| Revenue | $348.1M | $255.7M | +36.1% |
| Gross Profit | $222.0M | $155.2M | +43.1% |
| Operating Income | −$84.7M | −$110.5M | −23.3% |
| Net Income | −$125.9M | −$843.4M | −85.1% |
TEM Revenue by Segment
Figures from SEC filings and company reports. Not investment advice.